Literature DB >> 27364470

Reverse engineering liver buds through self-driven condensation and organization towards medical application.

Tadahiro Shinozawa1, Hiroshi Y Yoshikawa2, Takanori Takebe3.   

Abstract

The self-organizing tissue-based approach coupled with induced pluripotent stem (iPS) cell technology is evolving as a promising field for designing organoids in culture and is expected to achieve valuable practical outcomes in regenerative medicine and drug development. Organoids show properties of functional organs and represent an alternative to cell models in conventional two-dimensional differentiation platforms; moreover, organoids can be used to investigate mechanisms of development and disease, drug discovery and toxicity assessment. Towards a more complex and advanced organoid model, it is essential to incorporate multiple cell lineages including developing vessels. Using a self-condensation method, we recently demonstrated self-organizing "organ buds" of diverse systems together with human mesenchymal and endothelial progenitors, proposing a new reverse engineering method to generate a more complex organoid structure. In this section, we review characters of organ bud technology based on two important principles: self-condensation and self-organization focusing on liver bud as an example, and discuss their practicality in regenerative medicine and potential as research tools for developmental biology and drug discovery. Copyright Â
© 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Organ buds; Organoids; Self-condensation; Self-organization; iPS cells

Mesh:

Year:  2016        PMID: 27364470     DOI: 10.1016/j.ydbio.2016.06.036

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  11 in total

Review 1.  Reverse-engineering organogenesis through feedback loops between model systems.

Authors:  Cody Narciso; Jeremiah Zartman
Journal:  Curr Opin Biotechnol       Date:  2017-12-21       Impact factor: 9.740

Review 2.  Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.

Authors:  Stacey S Huppert; Kathleen M Campbell
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

Review 3.  Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application.

Authors:  Fanhong Zeng; Yue Zhang; Xu Han; Jun Weng; Yi Gao
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

Review 4.  Direct Lineage Reprogramming: Harnessing Cell Plasticity between Liver and Pancreas.

Authors:  Silvia Ruzittu; David Willnow; Francesca M Spagnoli
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

Review 5.  Liver Organoids: Formation Strategies and Biomedical Applications.

Authors:  Xinglong Zhu; Bingqi Zhang; Yuting He; Ji Bao
Journal:  Tissue Eng Regen Med       Date:  2021-06-16       Impact factor: 4.451

6.  Reprogramming human gallbladder cells into insulin-producing β-like cells.

Authors:  Feorillo Galivo; Eric Benedetti; Yuhan Wang; Carl Pelz; Jonathan Schug; Klaus H Kaestner; Markus Grompe
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

7.  A new strategy to measure intercellular adhesion forces in mature cell-cell contacts.

Authors:  Ana Sancho; Ine Vandersmissen; Sander Craps; Aernout Luttun; Jürgen Groll
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

8.  Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes.

Authors:  Nao Komatsu; Mikihito Kajiya; Souta Motoike; Manabu Takewaki; Susumu Horikoshi; Tomoyuki Iwata; Kazuhisa Ouhara; Katsuhiro Takeda; Shinji Matsuda; Tsuyoshi Fujita; Hidemi Kurihara
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

9.  Blended electrospinning with human liver extracellular matrix for engineering new hepatic microenvironments.

Authors:  Rhiannon Grant; John Hallett; Stuart Forbes; David Hay; Anthony Callanan
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

10.  Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback.

Authors:  Yasutaka Tsujimoto; Hiroki Shichi; Hidenori Fukuoka; Masaaki Yamamoto; Itsuko Sato; Takamitsu Imanishi; Tomoaki Nakamura; Naoko Inoshita; Atsushi Ishida; Shozo Yamada; Yutaka Takahashi; Kazuo Chihara
Journal:  J Endocr Soc       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.